You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DISULFIRAM - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for disulfiram and what is the scope of freedom to operate?

Disulfiram is the generic ingredient in two branded drugs marketed by Odyssey Pharms, Teva Womens, Alvogen, Chartwell Molecules, Dash Pharms, Hikma, Sigmapharm Labs Llc, Strides Pharma, Watson Labs, and Watson Labs Teva, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for disulfiram. Four suppliers are listed for this compound.

Summary for DISULFIRAM
Drug Prices for DISULFIRAM

See drug prices for DISULFIRAM

Recent Clinical Trials for DISULFIRAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang UniversityN/A
College of Pharmaceutical Sciences at Zhejiang UniversityN/A
First People's Hospital of HangzhouN/A

See all DISULFIRAM clinical trials

Pharmacology for DISULFIRAM
Medical Subject Heading (MeSH) Categories for DISULFIRAM

US Patents and Regulatory Information for DISULFIRAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma DISULFIRAM disulfiram TABLET;ORAL 202652-002 Feb 5, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs DISULFIRAM disulfiram TABLET;ORAL 087973-001 Aug 5, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs DISULFIRAM disulfiram TABLET;ORAL 087974-001 Aug 5, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Womens ANTABUSE disulfiram TABLET;ORAL 007883-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs DISULFIRAM disulfiram TABLET;ORAL 086889-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.